Abiomed, Inc.

Industry

  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Implantable Devices

Other Names/Subsidiaries

  • Breethe
  • preCARDIA, Inc.
  • BeneCor Heart Systems
  • Impella CardioSystem
See more in Biomedtracker

Latest on Abiomed, Inc.

Scrip

Stock Watch: J&J Puts On A Brave Face Ahead Of Stelara Biosimilars

 
• By Andy Smith

Volatile Reactions To Benign Results Johnson & Johnson (J&J) kicked off the third-quarter earnings season for the life sciences with a mixed but generally positive reception. The company’s st

Medtech Insight

J&J Acquires Heart Failure Implant Company V-Wave For Up To $1.7Bn, Expanding Its Medtech Portfolio In Cardiology

 
• By Marion Webb

Johnson & Johnson (Pty) Ltd has entered into a definite agreement to buy V-Wave Ltd. in a deal valued at potentially $1.7bn, which marks its second major deal in medtech this year, following the $

Scrip

Stock Watch: Investor Reactions Diverge As J&J And Novartis Report Q2 Results

 
• By Andy Smith

Second-Quarter Tipping Point With the 15% year-to-date gain of the S&P 500 index driven mainly by the largest artificial intelligence and technology companies, it was down to the second-quarter earnin

Scrip

Stock Watch: Is Johnson & Johnson Edging Away From Pharma?

 
• By Andy Smith

In The Shade With A Cold Shoulder As usual, Johnson & Johnson opened first-quarter 2024 earnings season for life sciences companies, reporting sales that grew by just over 2% on the same quarter of